Absorbine Jr.

Description

ABORBINE jr. PLUS is a pain-relieving liquid formulation containing 4% menthol as the active ingredient. The product is presented in a 4 fluid ounce (118 ml) volume. It is characterized by its fast-absorbing, deep-penetrating, non-greasy, and quick-drying properties, which facilitate easy application without stinging.

This formulation is indicated for the relief of sore muscles, arthritis pain, stiffness, aching joints, bruises, sprains, strains, backache, and foot pain and discomfort. ABSORBINE jr. PLUS has been providing quality relief since 1903 and is distributed by Clarion Brands, LLC, located at 27070 Miles Rd., Suite A, Solon, OH 44139. For further information, contact 1-844-922-7672 or visit the website at www.absorbinejr.com.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including arthritis, simple backache, sprains, strains, and bruises. It effectively alleviates sore muscles, arthritis pain, aching joints and stiffness, as well as discomfort related to bruises, sprains, strains, backache, and foot pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application frequency is to apply the medication to the affected area no more than 3 to 4 times daily.

For children under 2 years of age, it is advised to consult a healthcare professional prior to use.

Contraindications

The product should not be applied to wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, it is contraindicated to bandage tightly, as this may impede circulation and lead to further complications.

Warnings and Precautions

For external use only; this product must be utilized strictly as directed to ensure safety and efficacy. It is important to note that the product is flammable. Therefore, it should be kept away from fire, flames, sparks, and heated surfaces. Users are advised to tighten the cap firmly after use to minimize the risk of ignition.

In the event of accidental ingestion, immediate medical assistance should be sought. Contacting a Poison Control Center or obtaining emergency medical help is crucial if the product is swallowed.

Healthcare professionals should instruct patients to discontinue use and consult their physician if their condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. Monitoring for these signs is essential to ensure appropriate management and intervention.

Side Effects

Patients should be aware that the product is for external use only and must be used strictly as directed. It is important to note that the product is flammable; therefore, it should be kept away from fire, flames, sparks, and heated surfaces. Users are advised to ensure that the cap is tightened firmly after use to minimize any risk.

In the event that the condition worsens or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients should discontinue use and consult a doctor.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Absorbine Jr. (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the medication may be applied to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, they should also seek medical advice.

While using this product, it is important to instruct patients to avoid contact with the eyes. They should not apply the product to wounds or damaged skin, and they should refrain from tightly bandaging the area where the product is applied.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It should be stored at room temperature, ensuring that it is kept away from fire, flames, sparks, and heated surfaces to maintain safety and efficacy.

After each use, the cap must be tightened firmly to prevent leakage and contamination. Additionally, it is crucial to keep the product out of reach of children to avoid accidental ingestion. In the event of accidental swallowing, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Additional Clinical Information

Patients aged 2 years and older are advised to apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, consultation with a doctor is recommended prior to use.

Clinicians should counsel patients to seek advice from a health professional if they are pregnant or breastfeeding. Patients should discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. It is important to avoid contact with the eyes, refrain from applying the medication to wounds or damaged skin, and not to bandage the area tightly.

Drug Information (PDF)

This file contains official product information for Absorbine Jr., including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)